These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31236432)

  • 21. A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.
    Brennan AT; Bonawitz R; Gill CJ; Thea DM; Kleinman M; Long L; McCallum C; Fox MP
    J Acquir Immune Defic Syndr; 2019 Sep; 82(1):1-8. PubMed ID: 31408450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental status of human immunodeficiency virus-exposed uninfected premature infants compared with premature infants who are human immunodeficiency virus unexposed and uninfected.
    Cox C; Potterton J; Rosie S
    S Afr J Physiother; 2020; 76(1):1401. PubMed ID: 32671275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Micronutrient and Nutritional Status of HIV-Exposed and HIV-Unexposed Malawian Infants in the First Year of Life: Assessment of Ferritin, Vitamin A, and D Status and Its Association with Growth.
    Floridia M; Galluzzo CM; Orlando S; Luhanga R; Mphwere R; Kavalo T; Andreotti M; Amici R; Ciccacci F; Marazzi MC; Giuliano M
    Nutrients; 2023 Jul; 15(14):. PubMed ID: 37513701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal Perinatal HIV Infection Is Associated With Increased Infectious Morbidity in HIV-exposed Uninfected Infants.
    Powis KM; Slogrove AL; Okorafor I; Millen L; Posada R; Childs J; Abrams EJ; Sperling RS; Jao J
    Pediatr Infect Dis J; 2019 May; 38(5):500-502. PubMed ID: 30461574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malaria burden in a birth cohort of HIV-exposed uninfected Ugandan infants living in a high malaria transmission setting.
    Kakuru A; Natureeba P; Muhindo MK; Clark TD; Havlir DV; Cohan D; Dorsey G; Kamya MR; Ruel T
    Malar J; 2016 Oct; 15(1):500. PubMed ID: 27756308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children.
    Brennan AT; Bonawitz R; Gill CJ; Thea DM; Kleinman M; Useem J; Garrison L; Ceccarelli R; Udokwu C; Long L; Fox MP
    AIDS; 2016 Sep; 30(15):2351-60. PubMed ID: 27456985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth patterns and their contributing factors among HIV-exposed uninfected infants.
    Ndiaye A; Suneson K; Njuguna I; Ambler G; Hanke T; John-Stewart G; Jaoko W; Reilly M
    Matern Child Nutr; 2021 Apr; 17(2):e13110. PubMed ID: 33269548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.
    von Mollendorf C; von Gottberg A; Tempia S; Meiring S; de Gouveia L; Quan V; Lengana S; Avenant T; du Plessis N; Eley B; Finlayson H; Reubenson G; Moshe M; O'Brien KL; Klugman KP; Whitney CG; Cohen C;
    Clin Infect Dis; 2015 May; 60(9):1346-56. PubMed ID: 25645212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: follow-up of two cohorts studied in infancy.
    Nicholson L; Chisenga M; Siame J; Kasonka L; Filteau S
    BMC Pediatr; 2015 Jun; 15():66. PubMed ID: 26048411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lower Preprandial Insulin and Altered Fuel Use in HIV/Antiretroviral-Exposed Infants in Cameroon.
    Jao J; Kirmse B; Yu C; Qiu Y; Powis K; Nshom E; Epie F; Tih PM; Sperling RS; Abrams EJ; Geffner ME; LeRoith D; Kurland IJ
    J Clin Endocrinol Metab; 2015 Sep; 100(9):3260-9. PubMed ID: 26133363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Immunological Outcomes of HIV-Exposed Uninfected and HIV-Unexposed Uninfected Children in the First 24 Months of Life in Western Kenya.
    Ray JE; Dobbs KR; Ogolla SO; Daud II; Midem D; Omenda MM; Nowacki AS; Beeson JG; Sabourin KR; Rochford R; Dent AE
    Res Sq; 2023 Jun; ():. PubMed ID: 37461578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.
    Morden E; Technau KG; Giddy J; Maxwell N; Keiser O; Davies MA
    PLoS One; 2016; 11(4):e0151762. PubMed ID: 27049853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neuropsychological development of human immunodeficiency virus-exposed uninfected infants/young children].
    Xia W; Zheng JR; Zheng M; Li WJ; Jiang CQ; Wu YT; Huang ZR; Guo GP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Sept 15; 24(9):967-972. PubMed ID: 36111712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodevelopment of HIV-Exposed and HIV-Unexposed Uninfected Children at 24 Months.
    Chaudhury S; Williams PL; Mayondi GK; Leidner J; Holding P; Tepper V; Nichols S; Magetse J; Sakoi M; Moabi K; Makhema J; Mdluli C; Jibril H; Seage GR; Kammerer B; Lockman S
    Pediatrics; 2017 Oct; 140(4):. PubMed ID: 28912368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired functionality of antigen presenting cells in HIV- exposed uninfected infants in the first six months of life.
    Jalbert E; Ghosh T; Smith C; Amaral FR; Mussi-Pinhata MM; Weinberg A
    Front Immunol; 2022; 13():960313. PubMed ID: 36032106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth Trajectories of HIV Exposed and HIV Unexposed Infants. A Prospective Study in Gweru, Zimbabwe.
    Mabaya L; Matarira HT; Tanyanyiwa DM; Musarurwa C; Mukwembi J
    Glob Pediatr Health; 2021; 8():2333794X21990338. PubMed ID: 33614842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of growth in HIV-exposed and HIV-uninfected infants in the Kabeho Study.
    Lane CE; Bobrow EA; Ndatimana D; Ndayisaba GF; Adair LS
    Matern Child Nutr; 2019 Jul; 15(3):e12776. PubMed ID: 30609287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Birth size and early pneumonia predict linear growth among HIV-exposed uninfected infants.
    Deichsel EL; Pavlinac PB; Richardson BA; Mbori-Ngacha D; Walson JL; McGrath CJ; Farquhar C; Bosire R; Maleche-Obimbo E; John-Stewart GC
    Matern Child Nutr; 2019 Oct; 15(4):e12861. PubMed ID: 31222958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurodevelopmental outcomes in HIV-infected and uninfected African children.
    Debeaudrap P; Bodeau-Livinec F; Pasquier E; Germanaud D; Ndiang ST; Nlend AN; Ndongo FA; Guemkam G; Penda CI; Warszawski J; Koecher D; Faye A; Tejiokem MC;
    AIDS; 2018 Nov; 32(18):2749-2757. PubMed ID: 30289800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial.
    Blanche S; Tylleskär T; Peries M; Kankasa C; Engebretsen I; Meda N; Tumwine JK; Singata-Madliki M; Mwiya M; Van de Perre P; Nagot N;
    Lancet HIV; 2019 May; 6(5):e307-e314. PubMed ID: 30814028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.